{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:32:57Z","timestamp":1787621577339,"version":"build-2736575974"},"reference-count":30,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2012,6,17]]},"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To estimate the age and type-specific distribution of low-risk (LR) human papillomavirus (HPV) types in cervical samples from women in the general population and to assess the distribution of LR-HPV without the coexistence of high-risk HPV types in different cytology and histology categories.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a cross-sectional study, liquid-based cytology samples (SurePath) were collected over a 3-year period. The samples were HPV tested by Hybrid Capture II (HC2; Digene) and genotyped using a PCR-based assay (INNO-LiPAv2; Innogenetics Inc.). A total of 40\u2008382 women (14\u201395\u2005years of age) were included in the study. By linkage with the nationwide Pathology Data Bank, the HPV test results were directly linked to cytological diagnoses made from the same samples and to subsequent histology results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 2790 women (6.9%) tested positive for LR-HPV types, with HPV6 and HPV70 being the most frequent types detected, whereas HPV11 was uncommon. The highest prevalence was observed in the youngest age group (\u226419\u2005years). The LR-HPV prevalence was 6.3% in women with normal cytology, 33.1% in atypical squamous cells of undetermined significance (ASCUS), 19.6% in low-grade squamous intraepithelial lesion and 12.7% in those with high-grade squamous intraepithelial lesion. When considering women with LR-HPV alone, the prevalence was 2.0% (normal cytology), 11.3% (ASCUS), 2.6% (low-grade squamous intraepithelial lesion) and 0.7% in women with high-grade squamous intraepithelial lesion, respectively. A similar pattern was observed in relation to the histological diagnoses with the majority of LR-HPV infections detected in CIN1 lesions (24.7%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>LR-HPV types alone are relatively common in ASCUS, whereas LR-HPV types without coexisting high-risk HPV types are virtually never detected in severe cervical lesions.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2011-050307","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T02:09:55Z","timestamp":1341626995000},"page":"627-632","source":"Crossref","is-referenced-by-count":15,"title":["The importance of low-risk HPV infection for the risk of abnormal cervical cytology\/histology in more than 40\u2008000 Danish women"],"prefix":"10.1136","volume":"88","author":[{"given":"Ann","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Iftner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Junge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Kr\u00fcger","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"issue":"Suppl 3","key":"2024051320561637000_88.8.627.1","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: epidemiology and transmission dynamics of genital HPV infection","volume":"24","author":"Burchell","year":"2006","journal-title":"Vaccine"},{"key":"2024051320561637000_88.8.627.2","doi-asserted-by":"crossref","unstructured":"Schiffman M Kjaer SK . Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003:14\u201319.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476"},{"key":"2024051320561637000_88.8.627.3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"2024051320561637000_88.8.627.4","unstructured":"Syrj\u00e4nen KJ . Natural history of genital human papillomavirus infections. In: Lacey C , ed. Papillomavirus reviews: Current research on Papillomaviruses. Leeds: Leeds University Press, 1996."},{"key":"2024051320561637000_88.8.627.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"2024051320561637000_88.8.627.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67069-9"},{"key":"2024051320561637000_88.8.627.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70158-5"},{"key":"2024051320561637000_88.8.627.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-139X(08)00317-0"},{"key":"2024051320561637000_88.8.627.9","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23712"},{"key":"2024051320561637000_88.8.627.10","unstructured":"Danish National Board of Health. Cervical Cancer Screening\u2014Recommendations. Copenhagen: Danish National Board of Health, 2007."},{"key":"2024051320561637000_88.8.627.11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21955"},{"key":"2024051320561637000_88.8.627.12","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.57.1.68"},{"key":"2024051320561637000_88.8.627.13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1380"},{"key":"2024051320561637000_88.8.627.14","doi-asserted-by":"publisher","DOI":"10.1086\/587698"},{"key":"2024051320561637000_88.8.627.15","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000204545.89516.0a"},{"key":"2024051320561637000_88.8.627.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.8.813"},{"key":"2024051320561637000_88.8.627.17","doi-asserted-by":"publisher","DOI":"10.1086\/428850"},{"key":"2024051320561637000_88.8.627.18","doi-asserted-by":"publisher","DOI":"10.1086\/320696"},{"key":"2024051320561637000_88.8.627.19","doi-asserted-by":"publisher","DOI":"10.1086\/338010"},{"key":"2024051320561637000_88.8.627.20","doi-asserted-by":"publisher","DOI":"10.1086\/373901"},{"key":"2024051320561637000_88.8.627.21","doi-asserted-by":"crossref","unstructured":"Iftner T Villa LL . Chapter 12: human papillomavirus technologies. J Natl Cancer Inst Monogr 2003:80\u20138.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003487"},{"key":"2024051320561637000_88.8.627.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.008"},{"key":"2024051320561637000_88.8.627.23","doi-asserted-by":"publisher","DOI":"10.1086\/421279"},{"key":"2024051320561637000_88.8.627.24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601515"},{"key":"2024051320561637000_88.8.627.25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21515"},{"key":"2024051320561637000_88.8.627.26","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800723"},{"key":"2024051320561637000_88.8.627.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.04.012"},{"key":"2024051320561637000_88.8.627.28","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21429"},{"key":"2024051320561637000_88.8.627.29","first-page":"261","article-title":"Human papillomaviruses","volume":"100B","year":"2011","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2024051320561637000_88.8.627.30","unstructured":"Danish National Board of Health. The Use of Liquid Based Cytology (LBC) and Conventional Pap Smear for Cervical Cancer Screening in Denmark\u2014A Health Technology assessment. Copenhagen: Danish National Board of Health, 2005."}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2011-050307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T04:20:51Z","timestamp":1715660451000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2011-050307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,12,3]]},"published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1136\/sextrans-2011-050307"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2011-050307","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,6]]}}}